SK281559B6 - Kombinácia atovakvonu s proguanilom, jej použitie a farmaceutický prostriedok - Google Patents

Kombinácia atovakvonu s proguanilom, jej použitie a farmaceutický prostriedok Download PDF

Info

Publication number
SK281559B6
SK281559B6 SK570-95A SK57095A SK281559B6 SK 281559 B6 SK281559 B6 SK 281559B6 SK 57095 A SK57095 A SK 57095A SK 281559 B6 SK281559 B6 SK 281559B6
Authority
SK
Slovakia
Prior art keywords
proguanil
atovaquone
combination
treatment
compound
Prior art date
Application number
SK570-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK57095A3 (en
Inventor
Winston Edward Gutteridge
David Brian Ashton Hutchinson
Victoria Susan Latter
Mary Pudney
Original Assignee
The Wellcome Foundation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10725687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK281559(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The Wellcome Foundation Limited filed Critical The Wellcome Foundation Limited
Publication of SK57095A3 publication Critical patent/SK57095A3/sk
Publication of SK281559B6 publication Critical patent/SK281559B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK570-95A 1992-11-26 1993-11-25 Kombinácia atovakvonu s proguanilom, jej použitie a farmaceutický prostriedok SK281559B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929224739A GB9224739D0 (en) 1992-11-26 1992-11-26 Medicaments
PCT/GB1993/002425 WO1994012164A1 (en) 1992-11-26 1993-11-25 Combination of atovaquone with proguanil for the treatment of protozoal infections

Publications (2)

Publication Number Publication Date
SK57095A3 SK57095A3 (en) 1996-05-08
SK281559B6 true SK281559B6 (sk) 2001-05-10

Family

ID=10725687

Family Applications (1)

Application Number Title Priority Date Filing Date
SK570-95A SK281559B6 (sk) 1992-11-26 1993-11-25 Kombinácia atovakvonu s proguanilom, jej použitie a farmaceutický prostriedok

Country Status (38)

Country Link
US (3) US5998449A (ja)
EP (1) EP0670719B1 (ja)
JP (1) JP3768231B2 (ja)
KR (1) KR100294802B1 (ja)
CN (1) CN1087935C (ja)
AP (1) AP517A (ja)
AT (1) ATE191340T1 (ja)
AU (1) AU685408B2 (ja)
BG (1) BG62595B1 (ja)
CA (1) CA2150234E (ja)
CY (1) CY2193B1 (ja)
CZ (2) CZ289171B6 (ja)
DE (1) DE69328307T2 (ja)
DK (1) DK0670719T3 (ja)
ES (1) ES2145114T3 (ja)
GB (1) GB9224739D0 (ja)
GR (1) GR3033745T3 (ja)
HK (1) HK1004468A1 (ja)
HU (1) HU225918B1 (ja)
IL (1) IL107755A (ja)
MX (1) MX9307402A (ja)
MY (1) MY114241A (ja)
NO (1) NO313225B1 (ja)
NZ (1) NZ257901A (ja)
OA (1) OA10352A (ja)
PE (1) PE55694A1 (ja)
PL (1) PL174323B1 (ja)
PT (1) PT670719E (ja)
RO (1) RO119280B1 (ja)
RU (1) RU2108092C1 (ja)
SA (1) SA93140434B1 (ja)
SG (1) SG45387A1 (ja)
SI (1) SI9300614A (ja)
SK (1) SK281559B6 (ja)
TW (1) TW253835B (ja)
UA (1) UA45948C2 (ja)
WO (1) WO1994012164A1 (ja)
ZA (1) ZA938832B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9424013D0 (en) * 1994-11-29 1995-01-18 Wellcome Found Medicaments
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
GB9822681D0 (en) * 1998-10-16 1998-12-09 Vitabiotics Ltd Method of treatment
MXPA01010125A (es) 1999-04-09 2002-06-04 Glaxo Group Ltd Combinacion de una preparacion para el tratamiento de la malaria.
US7104076B2 (en) * 2004-06-24 2006-09-12 Carrier Corporation Lubricant return schemes for use in refrigerant cycle
ITMI20070941A1 (it) * 2007-05-09 2008-11-10 Chimico Internazi0Nale S P A L Procedimento per la preparazione di naftochinoni trans2,3-disostituiti
EP2467358B1 (en) * 2009-08-20 2014-07-23 IPCA Laboratories Limited Novel complex for treatment and/or prophylaxis of parasitic infections
US20180055835A1 (en) 2016-08-25 2018-03-01 Immune Therapeutics Inc. Method for Treating And Preventing Protozoal Infections

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533648A (en) * 1949-03-05 1950-12-12 Joseph H Warburg Circular saw making
NL6411993A (ja) * 1963-10-18 1965-04-20
US3347830A (en) * 1964-07-30 1967-10-17 Grace W R & Co Process of polymerizing formaldehyde
GB1141735A (en) * 1966-11-23 1969-01-29 Pfizer & Co C Pharmaceutical anti-tumor composition
NL6817526A (ja) * 1968-01-24 1969-07-28
US3655699A (en) * 1970-03-02 1972-04-11 Pfizer Analogues of lapachol as antitumor agents
DE2601458A1 (de) * 1975-01-20 1976-07-22 Ciba Geigy Ag Loesliche, von phenylindandiaminen abgeleitete polyamide
EP0002228B1 (en) * 1977-11-22 1984-02-29 The Wellcome Foundation Limited Hydroxy naphthoquinone derivatives, their preparations for treating and preventing theileriosis in cattle and sheep, processes for their synthesis; naphthoquinone derivatives
US4485116A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
US4485117A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
US5053432A (en) * 1983-04-14 1991-10-01 Burroughs Wellcome Co. Naphthoquinone derivatives
JPS59196467A (ja) * 1983-04-23 1984-11-07 Nissan Motor Co Ltd 車輪速及びまたは車輪加減速度検出方法
DE68914930T2 (de) * 1988-08-16 1994-08-18 Wellcome Found Naphtochinone zur Behandlung und Prophylaxe von Pneumocystis carinii-Infektionen.
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
US5225184A (en) * 1988-08-16 1993-07-06 Burroughs Wellcome Co. Medicaments
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
GB8923254D0 (en) * 1989-10-16 1989-12-06 Wellcome Found Medicaments
US5014737A (en) * 1989-11-13 1991-05-14 Allan Berman Quartz integrated trough/sump recirculating filtered high-purity chemical bath
GB9121316D0 (en) * 1991-10-09 1991-11-20 Wellcome Found Heterocyclic compounds
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
DK0648121T3 (ja) * 1993-05-05 1997-02-24 Palo Alto Medical Found
US5529994A (en) * 1993-05-05 1996-06-25 Palo Alto Medical Foundation Treatment for toxoplasmosis
US5733932A (en) * 1995-01-06 1998-03-31 The Picower Institute For Medical Research Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions
US5744168A (en) * 1995-12-07 1998-04-28 The Procter & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5827543A (en) * 1995-12-07 1998-10-27 The Procter & Gamble Company Methods and compositions for the prevention and treatment of urogenital disorders
US5747476A (en) * 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
ZA983331B (en) * 1997-05-01 1998-10-27 Allegheny University Of The He Method for treating protozoal infections
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
MXPA01010125A (es) * 1999-04-09 2002-06-04 Glaxo Group Ltd Combinacion de una preparacion para el tratamiento de la malaria.

Also Published As

Publication number Publication date
MY114241A (en) 2002-09-30
SK57095A3 (en) 1996-05-08
IL107755A (en) 2000-10-31
EP0670719B1 (en) 2000-04-05
JPH08503938A (ja) 1996-04-30
SI9300614A (en) 1994-06-30
PT670719E (pt) 2000-09-29
HK1004468A1 (en) 1998-11-27
CA2150234E (en) 2005-03-22
SA93140434B1 (ar) 2004-09-01
PL309222A1 (en) 1995-10-02
KR100294802B1 (ko) 2001-09-17
NO951995D0 (no) 1995-05-19
CZ289171B6 (cs) 2001-11-14
PL174323B1 (pl) 1998-07-31
PE55694A1 (es) 1995-01-25
US6291488B1 (en) 2001-09-18
BG99656A (bg) 1996-04-30
CZ119295A3 (en) 1995-11-15
RU2108092C1 (ru) 1998-04-10
CZ289692B6 (cs) 2002-03-13
CA2150234C (en) 2001-01-16
JP3768231B2 (ja) 2006-04-19
EP0670719A1 (en) 1995-09-13
HU225918B1 (en) 2007-12-28
NO313225B1 (no) 2002-09-02
CN1091632A (zh) 1994-09-07
BG62595B1 (bg) 2000-03-31
DE69328307T2 (de) 2000-10-26
CN1087935C (zh) 2002-07-24
AP9300592A0 (en) 1994-01-31
CY2193B1 (en) 2002-11-08
DK0670719T3 (da) 2000-07-31
MX9307402A (es) 1994-07-29
AU685408B2 (en) 1998-01-22
IL107755A0 (en) 1994-02-27
GR3033745T3 (en) 2000-10-31
DE69328307D1 (de) 2000-05-11
CA2150234A1 (en) 1994-06-09
GB9224739D0 (en) 1993-01-13
US5998449A (en) 1999-12-07
HU9501537D0 (en) 1995-07-28
NO951995L (no) 1995-07-03
ATE191340T1 (de) 2000-04-15
OA10352A (en) 2001-10-22
AU5532294A (en) 1994-06-22
AP517A (en) 1996-08-23
SG45387A1 (en) 1998-01-16
WO1994012164A1 (en) 1994-06-09
US6166046A (en) 2000-12-26
RO119280B1 (ro) 2004-07-30
HUT71346A (en) 1995-11-28
UA45948C2 (uk) 2002-05-15
ZA938832B (en) 1995-05-25
TW253835B (ja) 1995-08-11
NZ257901A (en) 1997-01-29
ES2145114T3 (es) 2000-07-01

Similar Documents

Publication Publication Date Title
SK281559B6 (sk) Kombinácia atovakvonu s proguanilom, jej použitie a farmaceutický prostriedok
JPH02256614A (ja) 薬剤耐性原生動物感染の処置に於けるラクタムイミド類
DE68907566T2 (de) Phenoxy- und phenylthio-, amino-substituierte Benzocyclo-alkan-Derivate bei der Behandlung und Verhütung von arzneimittelresistenten Protozoen-Infektionen.
DK175716B1 (da) Anvendelse af en substitueret naphthoquinon eller et derivat deraf til fremstilling af et lægemiddel til behandling af toxoplasmose
JPH11228422A (ja) 抗マラリア剤
WO2013018069A1 (en) Combination of antimalarial agents
WO2015001799A1 (ja) バベシア症の治療剤及び予防剤
US20240166637A1 (en) Compounds and methods for treating malaria
UA73609C2 (en) 1-aminoalkylcyclohexanes as trypanocides
NZ209519A (en) 1--3- aminopropanol derivatives and pharmaceutical compositions
CZ242994A3 (en) 1,4-naphthoquinone derivatives exhibiting anti-protozoic and anti-parasitic activity
US20030199697A1 (en) Method for the treatment of malaria by the use of primaquine derivative n1-(3-ethylidinotetrahydrofuran-2-one) -n 4-(6-methoxy-8-quinolinyl)-1,4-pentanediamine as gametocytocidal agent
RU2275356C2 (ru) 4,4'-сульфонилбис-(n,n'-диметиламмониометиленанилин)-хлорид, 6-метил-2,4-диоксо-1,2,3,4-тетрагидропиримидин-5-сульфонат, фармацевтическая композиция на его основе

Legal Events

Date Code Title Description
TE4A Change of owner's address

Owner name: THE WELLCOME FOUNDATION LIMITED, BRENTFORD, MI, GB

Effective date: 20130905

MK4A Patent expired

Expiry date: 20131125